WebbSiva Therapeutics Inc. Chief Executive Officer – Len Pagliaro, PhD, has 18 years of experience with successful commercialization of biotechnology products, services, and licensing, following an academic career. He has managed R&D and business development teams, and brought product lines from concept through commercialization to acquisition. WebbContact: David Regan, CEO +1-902-536-1932 [email protected] About Sona Nanotech Inc. Sona Nanotech is a nanotechnology life sciences firm that has developed multiple proprietary methods for the manufacture of various types of gold nanoparticles.
Sona Nanotech Receives Technology Assessment Results from NCL
WebbSiva Therapeutics has raised a total of $2.6M in funding over 6 rounds. Their latest funding was raised on Aug 26, 2024 from a Venture - Series Unknown round. Siva Therapeutics is funded by 4 investors. Texas A&M New Ventures Competition and Breakout Labs are the most recent investors. Webb27 juli 2016 · Associate Director, business strategy & portfolio Cell Unit & IO-Circuits Oncology R&D. AstraZeneca. Apr 2024 - Jan 202410 months. … bangunan struktur baja
Sona Nanotech Closes Acquisition of Siva Therapeutics, Plans For …
WebbSiva Therapeutics headquarter office and corporate office address is located in Austin, TX United States. Where is Siva Therapeutics country origins? Siva Therapeutics was … Webb14 feb. 2024 · Siva Therapeutics holds two patents supporting the in vivo delivery of a thermal therapy, which is being designed to have multiple beneficial effects on tumors, … WebbLocation Austin, TX, US Currency USD Founded October 2010 Employees 3 Incorporation Type C-corp Website sivatherapeutics.com Company Summary Siva Therapeutics has a safe and effective approach to cancer treatment using nanotechnology to deliver heat - Targeted Hyperthermia - to solid tumors. bangunan suasana pjh